Top Stories
CureVac Can Finally Compete With Moderna. It’s an ‘Under-the-Radar mRNA Story.’
- CureVac is ready to compete in the big leagues with its vaccines, according to a UBS analyst who says the soaring stock has more room to rise. UBS analyst Eliana Merle upgraded the shares (ticker: CVAC) to Buy from Neutral and raised her 12-month target for the stocks price to $18 from $8 on Thursday. Merle listed recent clinical trial data and the biopharmaceutical company’s ability to gain market share as reasons for the upgrade.
Albums
Prophet: The Unreleased First Polydor Album
2004
Dancing on the Edge
1986
When a Guitar Plays the Blues
1985
You're Not Alone
1978
Loading Zone
1977
Street Called Straight
1976
Live Stock
1975
In the Beginning
1974
That's What I Am Here For
1974
Roy Buchanan
1972
Shake Rattle & Roy
2013
Rhino Hi-Five: Roy Buchanan
2007
Hot Wires
1987
Rescue Me
1975
Second Album
1974
Buch and the Snake Stretcher's
1972
Live at Town Hall 1974
2018
Loading Zone/You're Not Alone
2017
Telemaster Live in '75
2017
After Hours: The Early Years 1956-1962
2016
Shredding the Blues: Live at My Father's Place
2014
Live from Austin, TX [DVD]
2012
Live from Austin, TX
2012
Live at Rockpalast
2011
When a Telecaster Plays the Blues
2009
Live: Amazing Grace
2009
That's What I Am Here For/Rescue Me
2008
More Stories
- NewsBenzinga
Janney Analyst Starts Clovis Oncology At Buy, Expects Regulatory Approvals Coming In 2016
The share price of Clovis Oncology Inc (NASDAQ: CLVS ) has appreciated 7.57 percent in the last month, after having fallen 70.08 percent over the past three months. Janney’s Roy Buchanan has initiated ...
Thanks for your feedback! - NewsSeeking Alpha (Transcripts)
Corcept Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Corcept Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thanks for your feedback!
© 2023 Yahoo. All rights reserved.